关注
Joanna C Porter
Joanna C Porter
Professor in Respiratory Medicine, UCL, London
在 ucl.ac.uk 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial
CJ Fisher, JFA Dhainaut, SM Opal, JP Pribble, RA Balk, GJ Slotman, ...
Jama 271 (23), 1836-1843, 1994
13541994
‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19
S Mandal, J Barnett, SE Brill, JS Brown, EK Denneny, SS Hare, ...
Thorax 76 (4), 396-398, 2021
9532021
Lung cancer—where are we today? Current advances in staging and nonsurgical treatment
SG Spiro, JC Porter
American journal of respiratory and critical care medicine 166 (9), 1166-1196, 2002
5282002
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ...
The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021
5022021
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ...
The Lancet Respiratory Medicine 10 (8), 761-775, 2022
3062022
Integrins take partners: cross-talk between integrins and other membrane receptors
JC Porter, N Hogg
Trends in cell biology 8 (10), 390-396, 1998
2991998
LFA-1-induced T cell migration on ICAM-1 involves regulation of MLCK-mediated attachment and ROCK-dependent detachment
A Smith, M Bracke, B Leitinger, JC Porter, N Hogg
Journal of cell science 116 (15), 3123-3133, 2003
2972003
Mechanisms contributing to the activity of integrins on leukocytes
N Hogg, R Henderson, B Leitinger, A McDowall, J Porter, P Stanley
Immunological reviews 186 (1), 164-171, 2002
2342002
Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study
TM Drake, AB Docherty, EM Harrison, JK Quint, H Adamali, S Agnew, ...
American journal of respiratory and critical care medicine 202 (12), 1656-1665, 2020
2242020
Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19
ER Mann, M Menon, SB Knight, JE Konkel, C Jagger, TN Shaw, ...
Science immunology 5 (51), eabd6197, 2020
2162020
Neutrophil-derived MMP-8 drives AMPK-dependent matrix destruction in human pulmonary tuberculosis
CWM Ong, PT Elkington, S Brilha, C Ugarte-Gil, MT Tome-Esteban, ...
PLoS pathogens 11 (5), e1004917, 2015
2062015
Integrin cross talk: activation of lymphocyte function-associated antigen-1 on human T cells alters α4β1-and α5β1-mediated function
JC Porter, N Hogg
The Journal of cell biology 138 (6), 1437-1447, 1997
1871997
Combination of endobronchial ultrasound‐guided transbronchial needle aspiration with standard bronchoscopic techniques for the diagnosis of stage I and stage II pulmonary …
N Navani, HL Booth, G Kocjan, M Falzon, A Capitanio, JM Brown, ...
Respirology 16 (3), 467-472, 2011
1742011
Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit
JS Friedland, JC Porter, S Daryanani, JM Bland, NJ Screaton, MJJ Vesely, ...
Critical care medicine 24 (11), 1775-1781, 1996
1621996
Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac …
EC Wicks, LJ Menezes, A Barnes, SA Mohiddin, N Sekhri, JC Porter, ...
European Heart Journal-Cardiovascular Imaging 19 (7), 757-767, 2018
1422018
Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities
P Mehta, JC Porter, JJ Manson, JD Isaacs, PJM Openshaw, IB McInnes, ...
The Lancet Respiratory Medicine 8 (8), 822-830, 2020
1382020
Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials
LA Saketkoo, S Mittoo, D Huscher, D Khanna, PF Dellaripa, O Distler, ...
Thorax 69 (5), 436-444, 2014
1362014
Update in diagnosis and management of interstitial lung disease
TA Mikolasch, HS Garthwaite, JC Porter
Clinical medicine 16 (6), s71-s78, 2016
1332016
The lung in a cohort of rheumatoid arthritis patients—an overview of different types of involvement and treatment
AC Duarte, JC Porter, MJ Leandro
Rheumatology 58 (11), 2031-2038, 2019
1322019
Signaling through integrin LFA-1 leads to filamentous actin polymerization and remodeling, resulting in enhanced T cell adhesion
JC Porter, M Bracke, A Smith, D Davies, N Hogg
The Journal of Immunology 168 (12), 6330-6335, 2002
1152002
系统目前无法执行此操作,请稍后再试。
文章 1–20